Last updated: 2026-10-15 23:54:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Galmed Pharmaceuticals Ltd. (GLMD) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Galmed Pharmaceuticals Ltd. (GLMD) is trading at $-- in after-hours trading as of --, -- from the regular-session close of $--.
After-hours trading shows how investors are pricing GLMD after the regular session closes. The current after-hours price is -- the regular-session close, indicating -- after-hours sentiment.
Over the past seven days, Galmed Pharmaceuticals Ltd. (GLMD) moved from $4.04 to $4.63, representing a gain of 14.60% ($0.59).
The stock traded between $3.74 and $4.63 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 54.49 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Galmed Pharmaceuticals Ltd. (GLMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.